The intersection of metabolic dysfunction and psoriatic disease represents a promising frontier for therapeutic innovation
Business Type Supplier, Trading Company, Wholesaler Employee Count 8 Establishment 2018 Working Days To GST NO 09ASWPR8312E2Z5 Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD, Cash Explore Related Categories More Products From This Seller Seller Details GST - 09ASWPR8312E2Z5 Trusted Seller Noida, Uttar Pradesh CEO Mr
Retatrutide (5mg-10mg), Triple Incretin Receptor Agonist Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Introduction Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Retatrutide is a synthetic 39-residue peptide engineered as a balanced agonist of three distinct class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
Our qualified professionals will assess your hormonal levels and develop a personalized treatment plan to address any imbalances
